IRIS UniCatt

Ferrandina, Maria Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.448
EU - Europa 9.780
AS - Asia 8.391
SA - Sud America 1.902
AF - Africa 233
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 21
AN - Antartide 1
Totale 30.802
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.176
SG - Singapore 4.030
DE - Germania 2.787
CN - Cina 2.294
SE - Svezia 1.758
BR - Brasile 1.602
IT - Italia 1.171
FR - Francia 714
UA - Ucraina 709
PL - Polonia 674
IE - Irlanda 498
IN - India 466
GB - Regno Unito 450
VN - Vietnam 426
ID - Indonesia 323
FI - Finlandia 282
RU - Federazione Russa 262
TR - Turchia 137
CA - Canada 135
AR - Argentina 116
HK - Hong Kong 111
BD - Bangladesh 102
JP - Giappone 86
MX - Messico 77
NL - Olanda 76
BE - Belgio 74
IQ - Iraq 69
AT - Austria 59
ZA - Sudafrica 59
ES - Italia 57
CI - Costa d'Avorio 54
EC - Ecuador 46
IR - Iran 41
LT - Lituania 40
KR - Corea 36
MA - Marocco 34
PK - Pakistan 34
SA - Arabia Saudita 32
CZ - Repubblica Ceca 29
PY - Paraguay 29
VE - Venezuela 28
CL - Cile 25
UZ - Uzbekistan 25
CO - Colombia 24
EG - Egitto 22
KE - Kenya 22
RO - Romania 22
AE - Emirati Arabi Uniti 21
JO - Giordania 21
CH - Svizzera 17
IL - Israele 17
EU - Europa 16
AU - Australia 14
PH - Filippine 14
PE - Perù 13
UY - Uruguay 13
PA - Panama 12
BH - Bahrain 11
DZ - Algeria 11
GR - Grecia 11
JM - Giamaica 11
AL - Albania 10
AZ - Azerbaigian 10
DO - Repubblica Dominicana 10
HR - Croazia 10
HU - Ungheria 9
KZ - Kazakistan 9
TN - Tunisia 9
KG - Kirghizistan 8
LB - Libano 8
MD - Moldavia 8
OM - Oman 8
HN - Honduras 7
LV - Lettonia 7
BG - Bulgaria 6
MT - Malta 6
MY - Malesia 6
NP - Nepal 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
RS - Serbia 6
TT - Trinidad e Tobago 6
AM - Armenia 5
BO - Bolivia 5
NO - Norvegia 5
PT - Portogallo 5
CR - Costa Rica 4
ET - Etiopia 4
SN - Senegal 4
TJ - Tagikistan 4
TW - Taiwan 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
CG - Congo 3
DK - Danimarca 3
EE - Estonia 3
GE - Georgia 3
KW - Kuwait 3
MN - Mongolia 3
Totale 30.754
Salva come PNG Salva come JPEG
Città #
Chandler 1.875
Singapore 1.785
Ashburn 916
Warsaw 603
Beijing 515
Dublin 483
Jacksonville 441
San Mateo 408
Wilmington 312
New York 304
Jakarta 301
Nanjing 267
Hangzhou 241
Ann Arbor 223
Los Angeles 221
Rome 214
Houston 202
Boston 183
Dearborn 178
Hyderabad 174
Hefei 171
Fairfield 156
Ho Chi Minh City 154
Milan 154
Nürnberg 149
Moscow 145
Dallas 144
São Paulo 142
Woodbridge 142
Princeton 138
Cattolica 137
Frankfurt am Main 137
Munich 134
Seattle 129
Marseille 124
The Dalles 124
Lawrence 121
Hanoi 111
Redwood City 104
Hong Kong 96
Bremen 84
Buffalo 83
Nanchang 83
Helsinki 80
Izmir 74
Brussels 69
Chicago 68
Boardman 61
Cambridge 61
Leawood 60
London 59
Lancaster 57
Zhengzhou 57
Tokyo 56
Abidjan 54
University Park 54
Strasbourg 53
Mountain View 51
Kraków 47
Norwalk 47
Brooklyn 46
Detroit 46
Kunming 46
Belo Horizonte 45
Düsseldorf 43
Changsha 42
Hebei 42
Atlanta 41
Redmond 41
Shenyang 41
Toronto 41
Turku 41
Kent 40
Santa Clara 40
Guangzhou 38
Jiaxing 38
Rio de Janeiro 37
Augusta 36
Nuremberg 35
Seoul 34
Vienna 34
Denver 33
Johannesburg 33
Shanghai 33
Tianjin 33
Andover 31
Montreal 31
San Francisco 31
Amsterdam 29
Pune 27
Fremont 26
San Jose 26
Stockholm 26
Brasília 25
Chennai 25
Curitiba 25
Dhaka 25
Lappeenranta 25
Phoenix 25
Tashkent 23
Totale 15.195
Salva come PNG Salva come JPEG
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 834
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer 503
Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study 382
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 347
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial 337
Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence 291
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients 283
Evaluation of quality of life and emotional distress in endometrial cancer patients: A 2-year prospective, longitudinal study 219
I nuovi mezzi di contrasto nello studio delle patologie ginecologiche. Applicazioni diagnostiche e prospettive terapeutiche. 215
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results 209
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 207
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 203
Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer. 196
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series 196
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 191
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 183
Adrenomedullin in Ovarian Cancer: Foe In Vitro and Friend In Vivo? 180
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer. 177
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 170
Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging. 169
Prognostic role of Ca125 response criteria and RECIST criteria: analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer. 169
Role of minimally invasive surgery versus open approach in patients with early-stage uterine carcinosarcomas: a retrospective multicentric study 169
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 167
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery? 164
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 163
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 163
Ultrasound contrast examination to discriminate benign and malignant adnexal masses 160
Sonographic imaging of urinoma 160
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 157
A case of isolated ovarian recurrence from vulvar carcinoma. 155
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 153
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 153
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 152
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 152
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 151
Neuroendocrine stress response in patients undergoing benign ovarian cyst surgery by laparoscopy, minilaparotomy, and laparotomy 150
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 150
Color Doppler sonographic features of a Krukenberg tumor in pregnancy 147
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 147
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 146
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 146
Imaging in gynecological disease (1): ultrasound features of metastases in the ovaries differ depending on the origin of the primary tumor 145
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. 145
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study 142
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 142
Malignant transformation of Madelung's disease in a patient with a coincidental diagnosis of breast cancer: a case report. 140
High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes 140
Uterine inversion in association with uterine sarcoma: a case report with MRI findings and review of the literature 138
Ultrasound evaluation of intra-abdominal sites of disease to predict the likelihood of suboptimal cytoreduction in advanced ovarian cancer: a propective study 137
Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: a dose-escalation study. 136
Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia) 136
Female pelvis 135
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 134
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 134
Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: the experience at Gemelli hospital and a literature review 134
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients 133
Preoperative local-regional staging of endometrial cancer: transvaginal sonography versus magnetic resonance imaging 132
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 132
The 'lead vessel': a vascular ultrasound feature of metastasis in the ovaries. 130
Minimally invasive salvage lymphadenectomy in gynecological cancer patients: A single institution series 130
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 129
Epidermal growth factor levels in human breast cyst fluid 129
Robotic Surgery in Elderly and Very Elderly Gynecologic Cancer Patients 129
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 128
Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial 127
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 125
Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis 122
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer 121
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 119
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 119
Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients. 119
Successful multimodal treatment of a breast cancer patient with a recurrence invading the chest wall 118
Receptors for epidermal growth factor and steroid hormones in primary colorectal tumors 118
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 118
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 118
Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial 118
Ultrasound and color power Doppler in the detection of metastatic omentum: a prospective study 117
How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study 117
Sonographic features of primary ovarian fibrosarcoma: a report of two cases. 116
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 116
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 116
Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital 116
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 115
Optimizing treatment in recurrent epithelial ovarian cancer 115
Arterial-enteric fistula after pelvic lymphadenectomy in secondary cytoreductive surgery for recurrent ovarian cancer 115
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study 115
Prognostic Significance of Ultrasound Characteristics and Body Mass Index in Patients with Apparent Early-Stage Cervical Cancer: A Single-Center, Retrospective, Cohort Study 114
Serous ovarian carcinoma recurring as a heterologous carcinosarcoma 113
Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: a case report and review of the literature 113
Long-term survival of young endometrial cancer patients desiring fertility preservation treated with hysteroscopic resection followed by hormone therapy (NEMO technique) 112
Clinical Impact of Pathologic Residual Tumor in Locally Advanced Cervical Cancer Patients Managed by Chemoradiotherapy Followed by Radical Surgery: A Large, Multicenter, Retrospective Study 112
PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery 111
Epidermal growth factor levels in human breast cyst fluid 110
A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer 110
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 110
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? 109
Prognostic significance and clinical relevance of the expression of the HER family of type I receptor tyrosine kinases in human laryngeal squamous cell carcinoma 109
Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 108
Impact of aromatase inhibitor treatment on vertebral morphology and bone mineral density in postmenopausal women with breast cancer 108
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 108
Totale 16.023
Salva come PNG Salva come JPEG
Categoria #
all - tutte 136.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.020
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.270 0 0 0 0 0 102 265 64 204 182 362 91
2021/20222.576 283 157 47 255 121 64 46 407 108 192 387 509
2022/20235.153 689 708 409 780 339 628 223 384 624 138 153 78
2023/20242.461 100 725 67 157 73 319 178 87 47 96 313 299
2024/20255.404 134 135 387 186 481 177 226 244 827 661 1.037 909
2025/20267.247 2.081 393 822 1.517 2.316 118 0 0 0 0 0 0
Totale 32.078